MedPath

Comparison of Efficacy of Oral Fluconazole Versus Oral Itraconazole in the Treatment of Pityriasis Versicolor

Phase 4
Recruiting
Conditions
Pityriasis Versicolor
Interventions
Registration Number
NCT06922344
Lead Sponsor
Khyber Teaching Hospital
Brief Summary

This study compares the efficacy of two drugs, namely flucanazole and itraconazole for the treatment of a common fungal infection of skin.

Detailed Description

Pityriasis versicolor is a common fungal infection of the superficial skin layers. Avalible treatment options include topical and systemic drugs. fluconazole and itraconazole are commonly used systemic agents. The aim of this study is to compare the efficacy of the two systemic drugs.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
106
Inclusion Criteria
  • All cases of Pityriasis versicolor
Exclusion Criteria
  • Patients with history of chronic renal or liver disease, malignancy , or undergoing any kind of chemotherapy or radiotherapy or having cardiac conduction abnormalities.
  • Patients who received any anti-fungal therapy in the last one month.
  • Pregnant or lactating women.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group A, Fluconazole groupFluconazoleGroup A consists of patients in whom oral fluconazole is given in dose of 300mg once weekly for 2 weeks.
Group B, Itraconazole groupItraconazoleGroup B consists of patients in whom oral Itraconazole is given in dose of 100mg Twice for 5 days.
Primary Outcome Measures
NameTimeMethod
Efficacy of TreatmentUpto 8 weeks

Efficacy of treatment is defined by absence of scaling by naked eye examination ,absence of yellow or golden scale reflection on woods lamp examination and absence of fungal hyphae on microscopic examination.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Khyber Teaching Hospital

🇵🇰

Peshawar, KPK, Pakistan

© Copyright 2025. All Rights Reserved by MedPath